Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published Evidence.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 489, doi. 10.1007/s40259-016-0199-9
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2016 AND VI 30 AND IP 6
Results: 7
1
2
Identification of Potential Therapeutics to Conquer Drug Resistance in Salmonella typhimurium: Drug Repurposing Strategy.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 593, doi. 10.1007/s40259-016-0200-7
- By:
- Publication type:
- Article
3
Biosimilars for the Treatment of Chronic Inflammatory Diseases: A Systematic Review of Published Evidence.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 525, doi. 10.1007/s40259-016-0201-6
- By:
- Publication type:
- Article
4
Rheumatologists' Perceptions of Biosimilar Medicines Prescription: Findings from a French Web-Based Survey.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 585, doi. 10.1007/s40259-016-0202-5
- By:
- Publication type:
- Article
5
Acknowledgement to Referees.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 485, doi. 10.1007/s40259-016-0203-4
- Publication type:
- Article
6
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 571, doi. 10.1007/s40259-016-0204-3
- By:
- Publication type:
- Article
7
Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases.
- Published in:
- BioDrugs, 2016, v. 30, n. 6, p. 607, doi. 10.1007/s40259-016-0197-y
- By:
- Publication type:
- Article